OPTUS Pharmaceutical (131030) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, OPTUS Pharmaceutical (131030) reported revenue of 87.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202587.2 billion KRW8.9 billion KRW11.4 billion KRW[source]
202481.9 billion KRW8.6 billion KRW10.3 billion KRW[source]
202372.4 billion KRW8.2 billion KRW10.8 billion KRW[source]
202258.7 billion KRW5.3 billion KRW5.0 billion KRW[source]
202157.3 billion KRW10.5 billion KRW9.9 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025191.1 billion KRW26.1 billion KRW165.0 billion KRW[source]
2024166.5 billion KRW22.8 billion KRW143.7 billion KRW[source]
2023149.5 billion KRW15.0 billion KRW134.5 billion KRW[source]
2022136.2 billion KRW11.8 billion KRW124.5 billion KRW[source]
2021140.0 billion KRW13.0 billion KRW127.0 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice